[Breast Cancer: Targets and Therapy] A review of the data on this newer peptide vaccine being explored as potential vaccine therapy for HER2-positive and triple negative breast cancers.
Educational videos produced the highest rate of acceptability and knowledge.
A retrospective study sought to determine if incidence or severity of irAEs was affected by the seasonal influenza vaccine in patients undergoing immunotherapy.
iPSC vaccine prevented tumor growth in syngeneic murine breast CA, mesothelioma, melanoma models
Axalimogene filolisbac, an intravenous vaccine currently in clinical trials, could prevent often-fatal cervical cancer relapse.
A third clinical trial is beginning for phase I testing of SurVaxM, a cancer vaccine. This trial tests for safety and effectiveness of the vaccine in combination with lenalidomide as maintenance therapy for adults with multiple myeloma.
Scientists used a genetically engineered vaccine to successfully eradicate high-grade precancerous cervical lesions in nearly one-half of women who received the vaccine in a clinical trial.
Personalized melanoma vaccines can be used to galvanize a powerful immune response against unique mutations in patients’ tumors, according to early data in a first-in-people clinical trial.
A vaccine therapy designed to boost the body’s immune response may join available early treatment options for prostate cancer.
A breast cancer vaccine is safe in patients with metastatic breast cancer, as indicated by the results of an early clinical trial.
